1. Introduction {#sec1}
===============

Acute myocardial infarction (AMI) is the result of a precipitous decline in coronary artery blood flow. This condition seriously threatens human health. The restoration of blood flow can significantly improve prognosis. However, many studies have indicated that myocardial reperfusion can also induce additional damage to the myocardium, defined as myocardial ischemia/reperfusion (I/R) injury \[[@B1], [@B2]\]. Furthermore, clinical studies have determined that, even after receiving timely and optimal myocardial reperfusion, patients still experience a high rate of death and a high incidence of cardiac failure after AMI \[[@B3]\]. Myocardial I/R injury plays an important role in the process \[[@B1], [@B2]\]. Over the past 30 years, many cardioprotective strategies against I/R injury have been proposed. However, practice shows that the current effects are not ideal \[[@B4]\]. We need to further study the pathophysiological process of myocardial ischemia reperfusion and explore new therapeutic targets. Circular RNAs (circRNAs) are a large family of noncoding RNAs. These molecules are characterized by the formation of a covalently closed loop structure through joining the 3′ end of the RNAs to the 5′ end \[[@B5], [@B6]\]. Recently, circRNAs have become an area of increased research focus. Increasing research has confirmed the association between circRNAs and physiological and pathological development in many organisms. As microRNA (miRNA) sponges, circRNAs can interact with RNA binding proteins (RBPs) and control alternative splicing and parental gene expression. CircRNAs play an important regulatory role at the transcriptional and posttranscriptional levels \[[@B7]--[@B9]\]. An increasing number of studies have found that circRNAs are also involved in many kinds of cardiovascular diseases \[[@B10], [@B11]\]. However, the signature of circRNA expression and the possible roles of circRNAs in myocardial I/R injury have received relatively little attention. In this study, we tested the effects of myocardial I/R injury on circRNA expression and explored the potential roles of these circRNAs at the early stage of reperfusion.

2. Materials and Methods {#sec2}
========================

2.1. Animal {#sec2.1}
-----------

Male C57BL/6 mice (10--12 weeks old, body weight approximately 25 g, from Beijing Huafu Kang Animal Experiment Company) were used in this study. Animal experiments were conducted following the NIH Guide for Laboratory Animals. All mice were fed with standard mouse food and water. The protocol was approved by the Experimental Animal Ethics Committee of Shengjing Hospital of China Medical University, China (Animal Experimental Ethical Inspection Protocol No. 2017PS041K).

2.2. Myocardial I/R Injury Protocol {#sec2.2}
-----------------------------------

Six C57BL/6 mice were randomly assigned to two groups: the I/R group and the control group (sham group). Myocardial I/R was performed as described previously (45 min of ischemia followed by 2 h of reperfusion) \[[@B12]\]. Briefly, C57BL/6 mice were first anesthetized with pentobarbital (100 mg/kg, intraperitoneal injection), and an additional dose could be needed during the experiment to maintain anesthesia. This procedure was followed by intubation and ventilation. The left anterior descending artery (LAD) of each mouse was ligatured with an 8--0 prolene suture to induce myocardial ischemia, which was confirmed by the changes in the ECG and the presence of epicardial cyanosis. After 45 min of ischemia, the occlusion of the left anterior coronary artery was released and reperfusion occurred which was verified by visualizing a marked epicardial hyperemic response. Animals were sacrificed at the time of reperfusion (2 h after 45 min ischemia). At autopsy, samples were collected from the infarct region as quickly as possible \[[@B13]\] and the samples were confirmed by visual inspection under a dissecting microscope by discoloration of the occluded distal myocardium. The sham group underwent the same surgical procedure, including thread drawing, but not ligation at the same site. We collected samples from the control group in the myocardial region of the LAD blood supply.

2.3. High-Throughput circRNA Sequencing {#sec2.3}
---------------------------------------

High-throughput circRNA sequencing was performed in Beijing Novogene with six samples (3 samples from the control group and 3 from the I/R group). The procedure was as follows: after extracting the total RNA, the ribosomal RNA (rRNA) was removed from the total RNA. RNA-seq libraries were constructed. Then, double-strand complementary DNA (cDNA) was synthesized. After removing second-strand cDNA, first-strand cDNA was purified for PCR amplification. Then, the samples were sequenced with Illumina HiSeq™ 2500 (Illumina) using the paired end (PE) sequencing strategy according to the Illumina protocol. The raw data were recorded. Then, sequence quality was evaluated with the quality control software FastQC and C clean reads were available. Find_circ (v1.0) and CIRI2 were used to recognize circRNAs \[[@B14], [@B15]\].

2.4. Bioinformatic Analyses {#sec2.4}
---------------------------

The differential expression of circRNAs was analyzed by DEGseq \[[@B16]\]. Gene Ontology (GO) analysis (<http://www.geneontology.org/>) was used to obtain information about the gene-related biological processes and molecular functions \[[@B17]\]. Kyoto Encyclopedia of Genes and Genomes (KEGG; <http://www.kegg.jp>) pathway analysis was also performed to provide information about the molecular interaction and reaction networks of the differentially expressed circRNAs \[[@B18]\].

2.5. Quantitative Real-Time Polymerase Chain Reaction {#sec2.5}
-----------------------------------------------------

Quantitative real-time polymerase chain reaction (qPCR) was conducted to confirm the differential expression of circRNAs \[[@B19]\]. Total RNA from cardiac tissues was extracted using the TRIzol Reagent (Takara, Dalian, China). Primers were designed using Primer 5 software, and all primers spanned the distal ends of circRNAs. cDNA was synthesized using the PrimeScript™ RT Reagent Kit (Takara, Dalian, China). The qPCR analyses were performed using a TB Green™ Premix Ex Taq™ II (Takara, Dalian, China) and an ABI Q2Real-time PCR system (Applied Biosystems, Foster City, CA, USA). The relative expression of different circRNAs was calculated by the 2^−ΔΔCt^ method.

2.6. Statistical Methods {#sec2.6}
------------------------

Data are expressed as the means ± standard deviation. Student\'s *t*-test was performed for comparisons between two groups. Differences with *P* \< 0.05 were considered statistically significant.

3. Results {#sec3}
==========

3.1. Different Expression Profiles of circRNAs {#sec3.1}
----------------------------------------------

A total of 920 novel and 590 known circRNAs were detected by RNA sequencing in all samples. Among them, 39 were differentially expressed (19 up- and 20 downregulated) in the I/R group, compared with the control group. Volcano plots visualized the significantly differentially expressed circRNAs ([Figure 1](#fig1){ref-type="fig"}). Thirty-one circRNAs were identified as new circRNAs that had not been annotated in the circBase or Circ2Traits database \[[@B20], [@B21]\]. The results of hierarchical clustering suggested that the circRNA expression patterns were distinguishable between the I/R and control groups ([Figure 2](#fig2){ref-type="fig"}). All dysregulated circRNAs are listed in [Table 1](#tab1){ref-type="table"}.

3.2. Validation of circRNA Expression {#sec3.2}
-------------------------------------

To verify the RNA sequencing data, we randomly selected 13 dysregulated circRNAs including 7 upregulated circRNAs (0001379, 0002875, 0002877, 0004342, 0000425, 0003835, and 0003928) and 6 downregulated circRNAs (0001747, 0001472, 0001058, 0002263, 0002430, and 0002612) for verification in samples. A general consistency was shown between the real-time PCR and sequencing analysis results. Four selected upregulated circRNAs and six selected downregulated circRNAs were confirmed (Figures [3(a)](#fig3){ref-type="fig"} and [3(b)](#fig3){ref-type="fig"}).

3.3. GO and KEGG Analyses {#sec3.3}
-------------------------

GO analysis of the host genes of the differentially expressed circRNAs was used to predict the circRNA functions including three domains: biological process, cellular component, and molecular function. [Table 2](#tab2){ref-type="table"} shows the top 10 enriched GO terms in biological process, cellular component, and molecular function, respectively. The most significant GO functions were associated with 3-5 RNA helicase activity, RNA polymerase II transcription factor binding, condensed chromosome outer kinetochore, condensed chromosome kinetochore, mitochondrial ncRNA surveillance, and mitochondrial mRNA surveillance. Additionally, the molecular interactions among the genes were explored by KEGG pathway analysis. The results are presented in [Figure 4](#fig4){ref-type="fig"}. The host genes of the differentially expressed circRNAs were mainly associated with adherens junction, the HIF-1 signaling pathway, the cell cycle, and the FoxO signaling pathway.

3.4. Analysis of circRNA-miRNA Interactions {#sec3.4}
-------------------------------------------

It has been confirmed that circRNAs can regulate the expression of genes as miRNA sponges. Hence, we predicted the potential target miRNAs of the confirmed differentially expressed circRNAs using miRanda software. A circRNA-miRNA interaction network was constructed using Cytoscape3.4.0 software. Two confirmed circRNAs (mmu_circRNA_0001379 and mmu_circRNA_0002263) were selected, and the circRNA/microRNA interaction was predicted. The potential miRNA targets of mmu_circRNA_0001379 include miR-153-5p, miR-130a-5p, and miR-17-5p (top 20, [Figure 5(a)](#fig5){ref-type="fig"}). For mmu_circRNA_0002263, the potential miRNA targets include miR-145a-5p, miR-145b, and miR-669p-5p (top 20, [Figure 5(b)](#fig5){ref-type="fig"}). It has been shown that miRNA-17-5p promoted cardiomyocyte apoptosis induced by oxidative stress via targeting Stat3 in an animal model of I/R injury \[[@B22]\], while the function of the most potential miRNAs on the heart are far from clear.

4. Discussion {#sec4}
=============

In this study, we exhibited the specific circRNA expression profile in I/R heart tissues at the early stage of reperfusion and provided some potential targets and pathways of the circRNA involved in I/R injury. These results provide important clues to reveal the role of circRNA in the pathologic process of cardiac I/R.

Based on the high-throughput sequencing data, we found significant upregulation of 19 circRNAs and downregulation of 20 circRNAs in the I/R group compared to the control group. Of them, 31 circRNAs were identified as new circRNAs that had not been annotated in the circBase database. Garikipati et al. performed circRNA microarray analysis using RNA isolated from sham or MI mouse hearts at day 3 post-MI. They found that 82 circRNAs were differentially expressed, including 41 upregulated and 41 downregulated \[[@B23]\]. Ge et al. found that a total of 185 significantly differentially expressed circRNAs were identified in EVs from the murine heart post-I/R injury, such as mmu-circ008351 and mmu-circ001007 \[[@B24]\]. Wu et al. applied a microarray assay to examine the transcriptome of circRNAs using a postmyocardial infarction model of heart failure in mice. They found that a total of 63 circRNAs were differential expressed, consisting of 29 upregulated circRNAs and 34 downregulated circRNAs \[[@B25]\]. We did not detect these circRNAs in our study, maybe because we used an I/R model at the early stage of reperfusion and one which is different from the model used in other studies.

To gain insight into the potential roles of the differentially expressed circRNAs in the infarct region, we performed GO and pathway analysis to predict the biological functions and mechanisms of the correlated targets. The most significant GO functions were associated with 3-5 RNA helicase activity, RNA polymerase II transcription factor binding, condensed chromosome outer kinetochore, condensed chromosome kinetochore, mitochondrial ncRNA surveillance, and mitochondrial mRNA surveillance. In order to get more credible biological functions, we used KEGG pathway analysis and found that the dysregulated transcripts were associated with adherens junction, the HIF-1 signaling pathway, the cell cycle, and the FoxO signaling pathway. Tansey et al. studied the reduction and redistribution of gap and adherens junction proteins after ischemia and reperfusion and they found that there are significant alterations in the structural integrity of the myocardium as well as gap and adherens junction protein expression with increasing global ischemia time \[[@B26]\]. Liu et al. found that microRNA-138 attenuates myocardial ischemia reperfusion injury through inhibiting mitochondria-mediated apoptosis by targeting HIF-1*α* \[[@B13]\]. Liem et al. found that the cell cycle proteins, Rb and Cdk2, are critical regulators of cardiac myocyte injury in vivo and support a cardioprotective role for Rb during I/R injury \[[@B27]\]. Qi et al. found that the FoxO3a pathway was involved in the I/R injury of cardiac microvascular endothelial cells (CMECs) at least in part through the regulation of cell cycle arrest and apoptosis \[[@B28]\]. Therefore, the four signaling pathways are involved with ischemia/reperfusion injury. Further researches are still needed to confirm these findings.

Large amounts of circRNAs have recently been discovered and represent a new special class of endogenous noncoding RNA. Recent studies have revealed that circRNAs are an abundant, stable, diverse, and conserved class of RNA molecules. Moreover, circRNAs can function as miRNA sponges or regulate parent gene expression to affect disease initiation and progression \[[@B11]\]. To date, many studies have reported associations between circRNAs and cardiovascular disease \[[@B10], [@B11]\]. The overexpression of circRNA CDR1as in hypoxic cardiomyocytes and mice with myocardial infarction has been found. CircRNA CDR1as could enhance the expression of the miR-7 target genes PARP and SP1 and increase the cardiac infarct size \[[@B29]\]. Recently, more studies revealed that circRNAs can function mainly as competing endogenous RNAs or miRNA sponges \[[@B11]\]. In our study, we found many dysregulated circRNAs in the heart tissue during I/R injury and we predicted the circRNA/microRNA interaction with miRanda software. We found that upregulated mmu_circRNA_0001379 can tightly bind miR-17-5p and is a potential sponge of miR-17-5p. A previous study also showed that miR-17-5p promoted cardiomyocyte apoptosis induced by oxidative stress via targeting Stat3 in both the animal model of I/R injury and the cellular model of cardiomyocyte injury induced by oxidative stress \[[@B22]\]. mmu_circRNA_0001379 may represent a new type of mediator of cardiac I/R injury. We infer that circRNA0001379 may act as an efficient miR-17-5p sponge and then affect the expression of downstream mRNAs. Due to the limited known function of circRNAs and miRNAs, many circRNA/microRNA interactions should be analyzed in the future.

However, there are some limitations in our study. First, the samples we selected are comparatively limited. In this study, we have only explored 3 control samples and 3 reperfusion samples for high-throughput sequencing analysis. More samples are needed to verify the results in future research. Second, the length of reperfusion time for sample collection was short and lasted only 2 h. Therefore, whether the expression of the circRNAs would show the same change after a longer period of ischemia is unknown. More studies in the future will be conducted for further exploration.

5. Conclusions {#sec5}
==============

In conclusion, we initiated an exploratory analysis of the expression of circRNAs at the early stage of reperfusion in the heart and investigated some of their potential roles and mechanisms. The identified circRNAs might serve as novel targets with further potential to prevent myocardial I/R injury.

The authors wish to thank the laboratory technician Bo Liu for assistance in animal experiments. This work was supported by the Social Development Research Program of Liaoning Province (No. 2011225020), the National Key R&D Program of China (No. 2018YFC1311600) and the 345 Talent Project of Shengjing Hospital.

Data Availability
=================

The data used to support the findings of this study are available from the corresponding author upon request.

Ethical Approval
================

All procedures performed in studies on animals were in compliance with the ethical standards of the NIH Guide for Laboratory Animals and approved by the Experimental Animal Ethics Committee of Shengjing Hospital of China Medical University, China (Animal Experimental Ethical Inspection Protocol No. 2017PS041K).

Conflicts of Interest
=====================

There is no conflict of interests in the financial or any other field.

Authors\' Contributions
=======================

All authors approved the manuscript.

![Volcano plots of the significantly differentially expressed circRNAs. CircRNAs were detected both in the I/R group and the control group. Compared with those in the control group, 39 were differentially expressed in the I/R group, among which 19 were upregulated (red dots) and 20 were downregulated (green dots). circRNAs: circular RNAs; REPERF: ischemia/reperfusion group.](BMRI2020-2346369.001){#fig1}

![Hierarchical clustering of circRNA expression patterns between the I/R group and control group. CircRNA expression patterns between the I/R group and control group were different. Overexpressed circRNAs are presented by red rectangles. Underexpressed circRNAs are presented by blue rectangles. REP: ischemia/reperfusion group; MCON: control group; circRNA: circular RNA.](BMRI2020-2346369.002){#fig2}

![To confirm the differential expression of circRNAs between the control group and the I/R group; qPCR was conducted. ^∗^*P* \< 0.05 and ^∗∗^*P* \< 0.01. qPCR: quantitative real-time polymerase chain reaction; I/R group: ischemia/reperfusion group.](BMRI2020-2346369.003){#fig3}

![Molecular interactions among genes explored by KEGG pathway analysis (top 20 pathways). KEGG enrichment was measured by rich factor, *Q* value, and gene number. A bigger value of rich factor means better enrichment. The lower value of *Q* value means better enrichment. KEGG: Kyoto Encyclopedia of Genes and Genomes.](BMRI2020-2346369.004){#fig4}

![circRNA-miRNA interaction network.](BMRI2020-2346369.005){#fig5}

###### 

Dysregulated circRNAs in the I/R group compared with those in the control group.

  CircRNA ID           Log~2~FC   *P* value   Regulation   Chromosome   Gene name
  -------------------- ---------- ----------- ------------ ------------ ---------------
  mmu_circ_0001058     -1.289     0.012       Down         2            Bub1b
  novel_circ_0001305   -1.002     0.040       Down         4            Rere
  novel_circ_0001874   -0.997     0.029       Down         X            6720401G13Rik
  novel_circ_0002430   -1.184     0.022       Down         10           Adarb1
  novel_circ_0003100   -0.827     0.042       Down         11           Sec24a
  novel_circ_0003626   -1.032     0.046       Down         12           Foxn3
  mmu_circ_0001352     -1.269     0.010       Down         5            Apbb2
  mmu_circ_0001747     -1.102     0.021       Down         9            Chordc1
  mmu_circ_0001770     -0.946     0.040       Down         9            Pafah1b2
  novel_circ_0000137   -0.912     0.045       Down         1            A330023F24Rik
  novel_circ_0000517   -0.946     0.040       Down         14           Erc2
  novel_circ_0000999   -1.299     0.008       Down         2            Dnm1
  novel_circ_0001472   -1.170     0.015       Down         6            Ezh2
  novel_circ_0001482   -1.054     0.025       Down         6            Prdm5
  novel_circ_0002035   -1.020     0.029       Down         10           Fam19a2
  novel_circ_0002115   -0.995     0.033       Down         10           Ahi1
  novel_circ_0002263   -1.070     0.024       Down         10           Ascc3
  novel_circ_0002612   -1.175     0.015       Down         10           None
  novel_circ_0002971   -0.919     0.044       Down         11           Psme4
  novel_circ_0003587   -0.995     0.033       Down         11           Npepps
  mmu_circ_0001379     3.448      0.000       Up           5            Zfp644
  novel_circ_0002569   3.005      0.000       Up           10           Rmst
  mmu_circ_0001295     1.786      0.001       Up           4            Rere
  novel_circ_0002875   0.481      0.004       Up           11           Vps54
  novel_circ_0002877   0.501      0.004       Up           11           Ugp2
  novel_circ_0004342   1.344      0.008       Up           12           None
  novel_circ_0000425   1.311      0.011       Up           12           Esyt2
  mmu_circ_0001380     1.086      0.021       Up           5            Zfp644
  novel_circ_0000366   1.104      0.032       Up           12           Dgkb
  novel_circ_0002885   0.847      0.040       Up           11           Ehbp1
  novel_circ_0003515   1.108      0.032       Up           11           Trim37
  novel_circ_0004746   0.898      0.039       Up           13           Hiatl1
  mmu_circ_0000997     1.081      0.023       Up           2            Prrc2b
  novel_circ_0000112   1.054      0.026       Up           1            Gpr161
  novel_circ_0000189   1.039      0.041       Up           10           Zfr2
  novel_circ_0003465   1.068      0.024       Up           11           Synrg
  novel_circ_0003835   1.142      0.018       Up           12           Asap2
  novel_circ_0003928   1.446      0.004       Up           12           None
  novel_circ_0003999   1.101      0.030       Up           12           Itsn2

circRNAs: circular RNAs; I/R group: ischemia/reperfusion group.

###### 

Top 10 enriched GO terms in molecular function, cellular component, and biological process.

  Term                                                                                                                            Term type            *P* value
  ------------------------------------------------------------------------------------------------------------------------------- -------------------- ------------
  3-5 RNA helicase activity                                                                                                       Molecular function   0.0010346
  RNA polymerase II transcription factor binding transcription factor activity involved in negative regulation of transcription   Molecular function   0.0015731
  Zinc ion binding                                                                                                                Molecular function   0.0015795
  Beta-N-acetylglucosaminidase activity                                                                                           Molecular function   0.0021346
  VEGF-A-activated receptor activity                                                                                              Molecular function   0.0038123
  VEGF-B-activated receptor activity                                                                                              Molecular function   0.0038123
  Placental growth factor-activated receptor activity                                                                             Molecular function   0.0038123
  Histone acetyltransferase activity                                                                                              Molecular function   0.0050248
  Transition metal ion binding                                                                                                    Molecular function   0.0052732
  Insulin-activated receptor activity                                                                                             Molecular function   0.0072851
  Condensed chromosome outer kinetochore                                                                                          Cellular component   0.00016441
  Condensed chromosome kinetochore                                                                                                Cellular component   0.00053713
  Condensed chromosome, centromeric region                                                                                        Cellular component   0.00098589
  Mitochondrial degradosome                                                                                                       Cellular component   0.0029943
  DBIRD complex                                                                                                                   Cellular component   0.0032617
  Intracellular organelle lumen                                                                                                   Cellular component   0.0054793
  Organelle lumen                                                                                                                 Cellular component   0.0055775
  Membrane-enclosed lumen                                                                                                         Cellular component   0.0061175
  Insulin receptor complex                                                                                                        Cellular component   0.007035
  Myosin complex                                                                                                                  Cellular component   0.0087096
  Mitochondrial ncRNA surveillance                                                                                                Biological process   0.0010346
  Mitochondrial mRNA surveillance                                                                                                 Biological process   0.0010346
  Cytoplasmic RNA surveillance                                                                                                    Biological process   0.0010346
  Mitochondrial RNA surveillance                                                                                                  Biological process   0.0010346
  Regulation of rho-dependent protein serine/threonine kinase activity                                                            Biological process   0.0011299
  Negative regulation of rho-dependent protein serine/threonine kinase activity                                                   Biological process   0.0011299
  Cellular response to heat                                                                                                       Biological process   0.0019831
  Regulation of cardiac muscle adaptation                                                                                         Biological process   0.0021346
  Negative regulation of cardiac muscle adaptation                                                                                Biological process   0.0021346
  Regulation of cellular response to heat                                                                                         Biological process   0.0023189

GO: Gene Ontology.
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